Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U6 small nuclear RNA 213, pseudogene (RNU6-213P), is a **nonfunctional, processed pseudogene** originating from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential component of the spliceosome and is highly conserved due to its central role in splicing nuclear pre-mRNA[2][3]. The human genome contains hundreds of U6-related pseudogenes (including RNU6-213P), which are the result of retrotransposition events, often mediated by LINE-1 elements[4][1]. These pseudogenes are generally transcriptionally silent and do not produce functional RNA or protein, although their presence reflects historical retrotransposition activity and genome evolution[4][1]. **Additional context:** - The **canonical U6 snRNA** participates directly in the catalysis of splicing reactions, and its structural and evolutionary conservation highlights its critical biological function[2][3]. However, **RNU6-213P** itself lacks coding or catalytic ability and does not serve as a target for drugs or biomarker studies. - U6 snRNA-derived *pseudogenes* are markers of retrotransposon-mediated genomic changes, but they do not have established biological or disease roles[4][1]. **Summary:** RNU6-213P is a nomenclature for one of many U6 small nuclear RNA pseudogenes that are relics of genome evolution, are not protein-coding, and have no direct functional or therapeutic significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 213, pseudogene (RNU6-213P).